Last reviewed · How we verify
Nescafé Gold Blend (exposed)
At a glance
| Generic name | Nescafé Gold Blend (exposed) |
|---|---|
| Sponsor | The Danish Epdiemiology Science Centre |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
- Caffeine is a stimulant used to treat drowsiness and increase alertness.
Common side effects
- Jitters
- Insomnia
- Anxiety
- Headache
- Stomach upset
Key clinical trials
- Effect of Caffeine on Fetal Growth (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nescafé Gold Blend (exposed) CI brief — competitive landscape report
- Nescafé Gold Blend (exposed) updates RSS · CI watch RSS
- The Danish Epdiemiology Science Centre portfolio CI